These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 13436864

  • 1. Use of hyaluronidase in insulin coma therapy.
    HOLDEN JC, MCGUINNESS OL.
    Br Med J; 1957 Jul 13; 2(5036):85-6. PubMed ID: 13436864
    [No Abstract] [Full Text] [Related]

  • 2. Use of hyaluronidase in insulin coma.
    PARGITER RA.
    Dis Nerv Syst; 1957 May 13; 18(5):194-5. PubMed ID: 13427658
    [No Abstract] [Full Text] [Related]

  • 3. The use of hyaluronidase with insulin in insulin coma therapy.
    ALEXANDER SP, NEANDER JF.
    Psychiatr Q; 1956 Jan 13; 30(1):89-95. PubMed ID: 13323102
    [No Abstract] [Full Text] [Related]

  • 4. Measurements of effects of hyaluronidase in insulin coma treatment.
    SCHMIDT KE, TONG J.
    J Ment Sci; 1958 Oct 13; 104(437):1136-48. PubMed ID: 13621159
    [No Abstract] [Full Text] [Related]

  • 5. Hyaluronidase as an adjuvant in insulin shock therapy.
    TYNDEL M.
    J Am Med Assoc; 1956 Sep 01; 162(1):32-4. PubMed ID: 13357285
    [No Abstract] [Full Text] [Related]

  • 6. [Considerations on the facilitating action of hyaluronidase in insulin coma].
    SACERDOTI G.
    Rass Studi Psichiatr; 1951 Sep 01; 40(2):299-308. PubMed ID: 14854269
    [No Abstract] [Full Text] [Related]

  • 7. A new aid to insulin coma therapy.
    GREENBANK RK.
    Psychiatr Q; 1954 Jul 01; 28(3):395-7. PubMed ID: 13204475
    [No Abstract] [Full Text] [Related]

  • 8. Hyaluronidase in insulin coma therapy.
    GYSIN WM, WILSON JL.
    Dis Nerv Syst; 1954 May 01; 15(5):138-41. PubMed ID: 13161747
    [No Abstract] [Full Text] [Related]

  • 9. [Advantages of hyaluronidase in the Sakel cure; preliminary clinical results].
    RONDEPIERRE J, HYVERT P, HENNE M, MARTY R, HAIM A, JAY M.
    Ann Med Psychol (Paris); 1953 Dec 01; 111(2 5):692-6. PubMed ID: 13148854
    [No Abstract] [Full Text] [Related]

  • 10. [Amorphous insulin & hyaluronidase in insulin treatment of psychoses].
    KEUP W.
    Schweiz Med Wochenschr; 1957 Aug 31; 87(35-36):1128-31. PubMed ID: 13467192
    [No Abstract] [Full Text] [Related]

  • 11. [Insulin sensitivity in schizophrenia; insulin economy with hyaluronidase].
    JOST F.
    Wien Klin Wochenschr; 1958 Sep 05; 70(36):657-61. PubMed ID: 13593351
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The cause of coma during insulin shock. Study based on change of extracellular fluid volume].
    OZAYDIN S.
    Encephale; 1962 Sep 05; 51():383-94. PubMed ID: 13940897
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Association of hyaluronidase to insulin in the Sakel treatment].
    DEMAY G, MISES R, BORIES J, CHANOIT P.
    Ann Med Psychol (Paris); 1953 Oct 05; 111(2 3):339-42. PubMed ID: 13105040
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.